Discontinued — last reported Q1 '23
Natera, Inc. Expensed In Process Research And Development increased by 15.3% to $2.68M in Q1 2023 compared to the prior quarter. Year-over-year, this metric grew by 15.3%, from $2.32M to $2.68M.
High spending indicates aggressive investment in future product pipelines, though it suppresses current earnings.
This represents the costs associated with research and development projects acquired in a business combination that have...
Common in biotech and pharmaceutical sectors where R&D pipelines are frequently bolstered by acquisitions.
operating_expensed_in_process_research_and_development| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | |
|---|---|---|---|---|---|---|---|---|
| Value | $8.90M | $8.90M | $8.90M | $2.32M | $2.32M | $2.32M | $2.32M | $2.68M |
| QoQ Change | — | +0.0% | +0.0% | -73.9% | +0.0% | +0.0% | +0.0% | +15.3% |
| YoY Change | — | — | — | — | -73.9% | -73.9% | -73.9% | +15.3% |